Skip to main content
. 2022 Apr 14;23(8):4280. doi: 10.3390/ijms23084280

Figure 2.

Figure 2

Influence of CYP2D6 polymorphisms and other cytochrome P450 enzymes in the metabolism of tamoxifen, an antineoplastic drug used in breast cancer, into its active and non-active forms. Reproduced from [45].